PURE Bioscience (PK:PURE)

Business Focus: Household Products

Jul 09, 2019 08:36 am ET
PURE Bioscience Announces Initiatives to Accelerate Drive Toward Profitability and Reduce Overhead
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that the Board of Directors has taken a number of initiatives to accelerate its goal of reaching profitability in calendar Q4 2019.
Jun 13, 2019 04:05 pm ET
PURE Bioscience Reports Fiscal 2019 Third Quarter and Nine-Month Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
May 22, 2019 08:36 am ET
PURE Bioscience Sets Fiscal 2019 Third Quarter and Nine-Month Financial Results Call
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on June 13, 2019 the Company will file its Form 10-Q shortly after the close of the market and will host an investor conference call that day at 1:30pm PT (4:30pm ET) to r
Mar 06, 2019 04:05 pm ET
PURE Bioscience Reports Fiscal 2019 Second Quarter and Six-Month Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
Mar 06, 2019 08:36 am ET
PURE Bioscience and SmartWash Solutions Announce Partnership for New Combined PURE Control®/SmartWash™ Antimicrobial Treatment for Produce
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
Feb 13, 2019 08:36 am ET
PURE Bioscience Sets Fiscal 2019 Second Quarter and Six-Month Financial Results Call
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on March 6, 2019 the Company will file its Form 10-Q shortly after the close of the market and will host an investor conference call that day at 1:30pm PT (4:30pm ET) to r
Dec 13, 2018 04:06 pm ET
PURE Bioscience Reports Fiscal 2019 Q1 Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (
Nov 29, 2018 04:06 pm ET
PURE Bioscience Sets Fiscal 2019 Q1 Financial Results Conference Call
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (
Nov 20, 2018 08:36 am ET
PURE Bioscience to Present at the 11th Annual LD Micro Conference
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (
Oct 25, 2018 04:06 pm ET
PURE Bioscience Reports Fiscal 2018 Year-End Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
Oct 08, 2018 08:36 am ET
PURE Bioscience Sets Conference Call to Report 2018 Fiscal Year-End Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on October 25, 2018 the Company will file its Form 10-K shortly after the close of the market and will host an investor conference call that day at 1:30pm PT (4:30pm ET) to
Oct 05, 2018 08:36 am ET
PURE Bioscience Appoints Chief Operating Officer
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
Aug 16, 2018 04:10 pm ET
PURE Bioscience Closes on $1.5 Million Financing and Provides Business Update
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
Jul 02, 2018 08:36 am ET
PURE Bioscience Raises $500,000 in Unsecured Promissory Note - Appoints Ivan Chen to Board of Directors
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
Jun 13, 2018 04:06 pm ET
PURE Bioscience Reports Fiscal 2018 Third Quarter and Nine-Month Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
May 30, 2018 08:36 am ET
PURE Bioscience Sets Conference Call to Report 2018 Fiscal Third Quarter and Nine-Month Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on June 13, 2018 the Company will file its Form 10-Q shortly after the close of the market and will host an investor conference call that day at 1:30pm PT (4:30pm ET) to re
Apr 26, 2018 08:36 am ET
PURE Bioscience Responds to the Latest Foodborne Illness Outbreak Tied to Romaine Lettuce
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (
Mar 14, 2018 04:06 pm ET
PURE Bioscience Reports Fiscal 2018 Second Quarter and Six-Month Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
Mar 08, 2018 09:00 am ET
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference
NEW YORK, March 8, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market presenting companies at the 30th Annual ROTH Conference, taking place March 11-14 at The Ritz Carlton in Dana Point, California. ...
Mar 01, 2018 08:36 am ET
PURE Bioscience Sets Fiscal 2018 Q2 Financial Results Conference Call
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on March 14, 2018 the Company will file its Form 10-Q shortly after the close of the market and will host an investor conference call that day at 1:30pm PT (4:30pm ET) to r
Feb 28, 2018 08:36 am ET
Feb 27, 2018 04:06 pm ET
PURE Bioscience to Present at the 30th Annual ROTH Capital Partners Conference
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
Jan 17, 2018 08:36 am ET
PURE Bioscience Receives Initial Orders from Leading Foodservice Distributor for PURE® Hard Surface Food Transport Sanitization Solution
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (
Dec 14, 2017 04:04 pm ET
PURE Bioscience Reports Fiscal 2018 Q1 Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (
Nov 28, 2017 08:36 am ET
PURE Bioscience Sets Fiscal 2018 Q1 Financial Results Conference Call
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on December 14, 2017 the Company will file its Form 10-Q shortly after the close of the market and will host an investor conference call that day at 1:30pm PST (4:30pm EST)
Nov 14, 2017 08:36 am ET
PURE Bioscience to Present at the 10th Annual LD Micro Conference
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (
Nov 02, 2017 08:36 am ET
PURE Bioscience Expands Board of Directors with Appointment of Elisabeth Hagen, M.D., Food Safety Consultant
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (
Oct 26, 2017 04:04 pm ET
PURE Bioscience Reports Fiscal 2017 Year-End Financial Results
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (
Oct 26, 2017 08:36 am ET
PURE Bioscience Announces Partnership with iGPS Logistics
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (
Oct 13, 2017 08:36 am ET
PURE Bioscience Announces Superior In-Plant Poultry Parts Test Results With PURE Control® Antimicrobial
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (
Oct 12, 2017 08:36 am ET
PURE Bioscience Completes Successful Warrant Tender Offer and Raises $2.8 Million from Exercise of Warrants
PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (
Jul 10, 2017 09:15 am ET
Roka Bioscience, Inc. Announces Co-Marketing and Supply Agreement with PURE Bioscience
WARREN, N.J., July 10, 2017 /PRNewswire/ -- Roka Bioscience, Inc. ("Roka") (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today that it has entered into a two year nonexclusive supply agreement with PURE Bioscience ("PURE") to market PURE's line of antimicrobial disinfecting and sanitizing processing aids to the food industry. ...